Share
Infectious Disease Diagnostics Market: Segmented: By Product (Assays & Reagents, Instruments, Software), By Disease Type (Hepatitis, Human Immunodeficiency Virus, Influenza, Others), By Technology (Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction, Next Generation Sequencing, Others), And Region - Global Analysis of Market Size, Share & Trends For 2019-2021 And Forecasts To 2031
[ 170 + Pages Research Report ] Infectious Disease Diagnostics Market to surpass USD 50.1 billion by 2031 from USD 25.6 billion in 2021 at a CAGR of 6.9% in the coming years, i.e., 2021-2031.
Infectious illness diagnosis is a diagnostic method that uses a variety of diagnostic tools to detect the presence of foreign antigens or organisms, and it is carried out by trained technicians or physicians. Various diagnosis procedures and devices are used to evaluate a sample of blood, urine, mucus, or other body fluids in order to offer information on the causative organism. The epidemiological burden of infectious diseases such as SARS, Middle East respiratory syndrome (MERS), chikungunya, Ebola, avian flu, Zika, and swine flu has paved the way for early detection and prevention.
Global Infectious Disease Diagnostics Market is expected to project a notable CAGR of 6.9% in 2031.
The market is being driven by factors such as the global prevalence of infectious diseases and rising awareness for early disease identification, a shift in focus from centralized laboratories to decentralized point-of-care testing, and technical breakthroughs. In addition, rising demand for point-of-care diagnostic tests and an increase in the prevalence of infectious diseases such as hepatitis, influenza, COVID-19, and human immunodeficiency virus (HIV) are driving market expansion.
The Assays & Reagents segment is expected to grow with the highest CAGR during 2021-31
Based on Product, the global Infectious Disease Diagnostics Market is fragmented into Assays & Reagents, Instruments, and Software. Due to the rising number of R&D activities in the pharmaceutical & biotechnology industry, increased demand for reagents, and increased use of point-of-care testing, the assays & reagents segment led the market in previous years, and this trend is expected to continue over the estimated period. However, due to an increase in the number of research laboratories and increased funding by government and private organizations for the development of diagnostic equipment, the instruments segment is projected to grow considerably throughout the forecast period.
The Others segment is expected to grow with the highest CAGR during 2021-31
Global Infectious Disease Diagnostics Market is classified on the basis of Technology into Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction, Next Generation Sequencing, and Others. Due to a large number of key players offering advanced diagnostic medical devices, increased demand for DNA analysis, development of novel & innovative PCR tools, and advancement in R&D activities for infectious disease diagnosis, the others segment dominated the market in 2020, and this trend is expected to continue during the forecast period.
The Growing Prevalence of Infectious Diseases across the globe
Infectious disease prevalence in both developed and developing nations will boost the infectious disease diagnostics market's growth. The growing number of prescriptions for contagious diseases diagnostic tests is because of the diagnosis and management of such illnesses. During the projection period, these factors, combined with the growing tendency toward preventive care, are projected to increase the demand for infectious disease diagnostics.
Increasing Geriatric Population that is prone to Infectious Diseases to drive the market
The rise in the geriatric population promotes market growth since older people are more susceptible to infectious diseases. Additionally, rising public awareness of the importance of early diagnosis and management of infectious diseases, as well as an increase in the number of information technology systems used to develop advanced diagnostic devices, are expected to provide lucrative opportunities for the global infectious disease diagnostic market to grow during the forecast period.
Unfavorable Reimbursement Policies
Inadequate reimbursement is a major stumbling block to the infectious disease diagnostics market. Most diagnostic companies have a significant barrier in commercializing their tests: convincing health insurers to pay for them.
Global Infectious Disease Diagnostics Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. In the year 2021, North America held the highest proportion of the global infectious illness diagnostics market. The high burden of infections, rising healthcare expenditure, implementation of favorable government initiatives, improved healthcare infrastructures, and easy access to technologically advanced instruments are all factors driving the growth of the infectious disease diagnostics market in North America.
Government organizations around the world are assisting laboratories in expediting COVID-19 testing methods since testing remains a critical step in preventing the disease's rapid spread. The COVID-19 pandemic had a negative influence on most companies' overall sales, but it had a favorable impact on the infectious illness diagnostics industry since infectious disease diagnostic procedures were used for COVID-19 testing.
Global Infectious Disease Diagnostics Market is further segmented by region into:
Infectious Disease Diagnostics Market Segments:
| Report Attribute | Details |
| Market size value in 2021 | USD 25.6 billion |
| Revenue forecast in 2031 | USD 50.1 billion |
| Growth Rate | CAGR of 6.9% from 2021 to 2031 |
| Base year for estimation | 2020 |
| Quantitative units | Revenue in USD million and CAGR from 2021 to 2031 |
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | Product, Disease Type, Technology, and Region |
| Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
| Key companies profiled | Abbott Laboratories, Becton Dickinson and Company, bioMerieus SA, Bio-Rad Laboratories, Danaher Corporation, F Hoffman-La Roche, Hologic Inc., Luminex Corporation, Qiagen Inc., Thermo Fisher Scientific Inc., and Other Prominent Players. |
Infectious Disease Diagnostics Market size was estimated at USD 25.6 billion in 2021 and is expected to reach USD 50.1 billion in 2031.
The diagnosis of infectious illnesses is labeled as a laboratory test used to diagnose the diseases with the help of skilled physicians and technicians.
The Assays & Reagents segment accounted for the largest Infectious Disease Diagnostics Market share.
Key players in the Infectious Disease Diagnostics Market include Abbott Laboratories, Becton Dickinson and Company, bioMerieus SA, Bio-Rad Laboratories, Danaher Corporation, F Hoffman-La Roche, Hologic Inc., Luminex Corporation, Qiagen Inc., Thermo Fisher Scientific Inc., and Other Prominent Players.
Infectious disease prevalence is predicted to rise, as is demand for point-of-care diagnostic tests, funding from private and government organisations for diagnostic service centres, and technological improvements in the field of infectious disease diagnostics.
Select License Type
Select License Type
FATPOS CLIENT Appriciation DURING THE PROJECT
Working with Fatpos Global, allowed us to take advantage of their knowledge and easy approach, allowing us to collect important data utilizing a variety of techniques. The results were clearly presented and explained, and FG responded to our questions with speed and expertise.
|
Swiss-based global building materials manufacturer |
The analyses and presentations Fatpos Global have produced for us have been of a very high caliber and have allowed us to proactively improve our customer relationship management. They have also done so while maintaining complete anonymity. Without any doubt, we suggest Fatpos Global to you.
|
|
Tech-powered construction company |
We appreciate the team’s punctuality, flexibility in terms of report modification, post report purchase support and pleasant reaction all around. Overall, my experience with this company was nothing but positive, and I couldn't be more grateful for their excellent service. Thank you for all that you do!
|
|
American global management consulting firm |
We are able to concentrate on the topics and implications that are most important to our clients thanks to the adaptability and responsiveness of the team at Fatpos Global. We would highly recommend this company to anyone in need of their services, and I will certainly be using them again in the future.
|
|
Headquartered in Zug, Switzerland, leading supplier of medical and surgical instrument |
To better study our client demographics, develop the ideal product-price architecture, and enhance our target marketing initiatives, we hired Fatpos Global. Every component of the project was completed, and we are very happy with the useful insights and actionable results.
|
|
Kosovan company, A leading organic fertilizers producer |
Thank you for your team's generous assistance, The final report was delivered to me, and I find it to be really helpful. Also, you may be sure that I will get in touch with you if I ever require fresh materials for market research. Gratitude once more.
|
|
German specialty chemicals company based in Cologne, Germany |
